Loading organizations...
§ Private Profile · Los Gatos, CA, USA
Medical device startup developing biodegradable nanoparticle technology for drug-coated balloons, focused on cardiovascular diseases.
Founded in 2018 by Marwan Berrada-Sounni, Mehdi Shishehbor, and Philippe Urbain, Advanced NanoTherapies is a Los Gatos, California-based medical device startup developing biodegradable nanoparticle technologies for cardiovascular applications. The company focuses on dual-API drug-coated balloons, specifically the SirPlux Duo, which delivers a combination of Sirolimus and Paclitaxel to treat coronary and peripheral artery diseases while preventing blood vessels from re-narrowing. Guided by prominent medical advisors Azeem Latib, Gary Ansel, and Peter Schneider, the firm recently received FDA Breakthrough Device Designation for the SirPlux Duo to treat small vessel coronary artery disease. Operating as a pre-revenue enterprise, the organization has raised over 17 million dollars in venture funding to finance its clinical trials and commercialization efforts. Beyond its primary cardiovascular focus, the underlying nanoparticle delivery platform possesses potential future applications across the neurology, otolaryngology, and orthopedics sectors.
Advanced NanoTherapies has raised $16.5M across 3 funding rounds.
Advanced NanoTherapies has raised $16.5M in total across 3 funding rounds.
Advanced NanoTherapies has raised $16.5M in total across 3 funding rounds.
Advanced NanoTherapies's investors include Cleveland Clinic, ForMed Ventures.
Advanced NanoTherapies has raised $16.5M across 3 funding rounds. Most recently, it raised $4.0M Other Equity in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 22, 2023 | $4M Venture Round | — | — | Announced |
| Jun 28, 2022 | $7.2M Series A | — | — | Announced |
| Oct 13, 2020 | $5.3M Seed | — | Cleveland Clinic, Formed Ventures | Announced |